Diagnostic options · UAE

Single Gene tests in Dubai & UAE

Compare available Single Gene tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

332

Listed price range

2,000.00–2,800.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Single Gene test prices

Showing 91–105 of 332 matching tests.

Single Gene diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-4153 EIF2AK4 Gene Pulmonary Veno-Occlusive Disease Type 2 Genetic Test This test identifies pathogenic variants in the EIF2AK4 gene associated with hereditary pulmonary veno-occlusive disease type 2.	Peripheral whole blood (EDTA tube)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the EIF2AK4 gene", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (indels)", "Copy Number Variants (CNVs)"] Parameters [] Preparation ["Pre-test genetic counselling is mandatory", "Signed consent and pedigree required"] Indications ["Suspected hereditary pulmonary veno-occlusive disease type 2", "Familial risk stratification for PVOD type 2"] Measurement technique Confirm with laboratory Codes LOINC: 81321-9 ICD-10: I27.89, Z13.83 Clinical summary This test identifies pathogenic variants in the EIF2AK4 gene associated with hereditary pulmonary veno-occlusive disease type 2.
TEST-4875 ELK1 Gene Mental Retardation Non-Syndromic Genetic Test This test identifies pathogenic variants in the ELK1 gene associated with non-syndromic intellectual disability.	Peripheral whole blood	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ELK1 gene", "Single nucleotide variants (SNVs)", "Small insertions and deletions (indels)", "Copy number changes"] Parameters [{"name": "ELK1 Gene Variants", "reference_range": "No pathogenic variants detected"}] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Diagnosis of non-syndromic intellectual disability", "Family planning and genetic counseling", "Confirmation of suspected ELK1-related disorder"] Measurement technique Confirm with laboratory Codes LOINC: 81247-7 ICD-10: Z13.71, Z14.8, F79 Clinical summary This test identifies pathogenic variants in the ELK1 gene associated with non-syndromic intellectual disability.
TEST-5000 ENPP1 Gene Hypophosphatemic Rickets, Autosomal Recessive Type 2 Genetic Test This test identifies biallelic pathogenic variants in the ENPP1 gene associated with autosomal recessive hypophosphatemic rickets type 2.	Whole Blood (EDTA), Extracted DNA, or FTA Card Blood Spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ENPP1 gene", "Biallelic mutations causing ARHR2"] Parameters [] Preparation ["No specific fasting required", "Continue prescribed medications unless advised otherwise"] Indications ["Suspected autosomal recessive hypophosphatemic rickets type 2", "Family history of ARHR2", "Need for definitive molecular diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: E83.31 Clinical summary This test identifies biallelic pathogenic variants in the ENPP1 gene associated with autosomal recessive hypophosphatemic rickets type 2.
TEST-4451 ERCC4 Gene Genetic Test for XFE Progeroid Syndrome This test identifies pathogenic variants in the ERCC4 gene associated with XFE progeroid syndrome.	Peripheral whole blood or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ERCC4 gene variants (SNVs, indels, CNVs)"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist about bleeding disorders or anticoagulant use"] Indications ["Suspected XFE progeroid syndrome", "Family history of XFE progeroid syndrome", "Personal history of skin, immunological, or oncological manifestations suggestive of the syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 21679-7 ICD-10: E34.8 Clinical summary This test identifies pathogenic variants in the ERCC4 gene associated with XFE progeroid syndrome.
TEST-5697 ERLIN1 Gene (SPG62) Test This test identifies mutations in the ERLIN1 gene associated with autosomal recessive hereditary spastic paraplegia type SPG62.	Whole Blood (EDTA) – Peripheral Blood	3 to 4 Weeks (21–28 business days)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Mutations in the ERLIN1 gene", "Coding exons and splice-site regions"] Parameters [] Preparation ["Genetic counseling session and pedigree chart required before sample collection.", "Inform phlebotomist of any anticoagulant use or bleeding disorders."] Indications ["Diagnosis of Hereditary Spastic Paraplegia Type 62 (SPG62)", "Patients with clinical features suggestive of SPG62"] Measurement technique Confirm with laboratory Codes LOINC: 48018-6 ICD-10: G11.4 Clinical summary This test identifies mutations in the ERLIN1 gene associated with autosomal recessive hereditary spastic paraplegia type SPG62.
TEST-6055 ETFA Gene (Multiple Acyl‑CoA Dehydrogenase Deficiency) Genetic Test This genetic test evaluates the ETFA gene for mutations associated with Multiple Acyl-CoA Dehydrogenase Deficiency (MADD).	Peripheral Whole Blood (EDTA) or Saliva (Oragene® DNA Kit)	21–28 Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ETFA gene sequence", "Single nucleotide variants (SNVs)", "Insertions/Deletions (Indels)", "Copy Number Variations (CNVs)"] Parameters [] Preparation ["No fasting required", "Provide detailed clinical history", "Provide three-generation pedigree chart", "Pre-test genetic counselling required"] Indications ["Suspected diagnosis of Multiple Acyl-CoA Dehydrogenase Deficiency (MADD)", "Family history of MADD", "Carrier screening in at-risk individuals", "Pre-implantation genetic diagnosis (PGD)"] Measurement technique Confirm with laboratory Codes LOINC: 94222-0 ICD-10: E71.320 Clinical summary This genetic test evaluates the ETFA gene for mutations associated with Multiple Acyl-CoA Dehydrogenase Deficiency (MADD).
TEST-4605 EXOC8 Gene Joubert Syndrome Genetic Test This test identifies pathogenic variants in the EXOC8 gene associated with Joubert syndrome.	Whole blood (3–5 mL EDTA) or FTA card (dried blood spot)	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["EXOC8 gene pathogenic variants"] Parameters [] Preparation [] Indications ["Clinical signs suggesting Joubert syndrome", "Genetic confirmation for diagnosis", "Family planning and recurrence risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 31208-2 ICD-10: Q04.3 Clinical summary This test identifies pathogenic variants in the EXOC8 gene associated with Joubert syndrome.
TEST-2656 EXT1 Gene (Langer‑Giedion Syndrome) Genetic Test This test identifies pathogenic variants, including point mutations, small insertions/deletions, and large deletions, within the EXT1 gene.	Whole blood, extracted genomic DNA, or dried blood spot (FTA card)	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single-nucleotide variants (SNVs)", "Small insertions/deletions (indels)", "Large contiguous gene deletions (CNVs)", "Pathogenic variants in EXT1 gene"] Parameters [] Preparation ["A detailed clinical history and three-generation pedigree must be provided prior to sample collection.", "A mandatory genetic counselling session (onsite or telehealth) will be arranged.", "No drug or dietary restrictions are required before blood draw; maintain usual medication schedule unless advised otherwise by your physician."] Indications ["Clinical features suggestive of Langer‑Giedion syndrome", "Clinical features suggestive of hereditary multiple exostoses", "Unexplained dysmorphic features with intellectual disability"] Measurement technique Confirm with laboratory Codes LOINC: 101423-6 ICD-10: Q87.8, Q87.0, Z15.89 Clinical summary This test identifies pathogenic variants, including point mutations, small insertions/deletions, and large deletions, within the EXT1 gene.
TEST-2332 EXT2 Gene Sequencing (Seizures, Scoliosis, Macrocephaly Syndrome) NGS Test This test identifies pathogenic variants within the EXT2 gene associated with seizures, scoliosis, and macrocephaly syndrome.	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA card)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the EXT2 gene"] Parameters [] Preparation ["No specific fasting required", "Inform lab of current medications"] Indications ["Suspected EXT2-related syndrome", "Family history of EXT2-related syndrome", "Guiding anti-epileptic therapy", "Orthopaedic planning", "Family cascade screening"] Measurement technique Confirm with laboratory Codes LOINC: 93835-9 ICD-10: G40.9 Clinical summary This test identifies pathogenic variants within the EXT2 gene associated with seizures, scoliosis, and macrocephaly syndrome.
TEST-2471 EYA1 Gene Otofaciocervical Syndrome Genetic Test This genetic test analyzes the EYA1 gene for mutations associated with otofaciocervical syndrome.	Peripheral Blood, Extracted DNA, or FTA Card Sample	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the EYA1 gene"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medication"] Indications ["Clinical suspicion of otofaciocervical syndrome", "Family history of otofaciocervical syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 77642-5 ICD-10: Q87.0, Q18.8, Z13.71 Clinical summary This genetic test analyzes the EYA1 gene for mutations associated with otofaciocervical syndrome.
TEST-5085 FAM111A Gene Gracile Bone Dysplasia Genetic Test This test identifies pathogenic variants in the FAM111A gene to confirm a diagnosis of gracile bone dysplasia.	Peripheral Whole Blood	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the FAM111A gene", "Copy Number Variations (CNVs) in FAM111A"] Parameters [] Preparation ["Provide detailed clinical history", "Provide pedigree chart from prior genetic counselling"] Indications ["Suspected gracile bone dysplasia", "Family history of gracile bone dysplasia", "Need for precise molecular confirmation for clinical management"] Measurement technique Confirm with laboratory Codes LOINC: 94474-1 ICD-10: Q78.8 Clinical summary This test identifies pathogenic variants in the FAM111A gene to confirm a diagnosis of gracile bone dysplasia.
TEST-4696 FAM111A Gene Test for Kenny‑Caffey Syndrome Type 2 (NGS) This diagnostic test evaluates the FAM111A gene for pathogenic variants associated with Kenny‑Caffey syndrome type 2.	Whole Blood / FTA Card / Extracted DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the FAM111A gene", "Copy number variations in the FAM111A gene"] Parameters [] Preparation ["Do not discontinue prescribed medication without doctor’s approval"] Indications ["Suspected Kenny‑Caffey syndrome type 2", "Carrier screening", "Family planning"] Measurement technique Confirm with laboratory Codes LOINC: 81304-3 ICD-10: Q87.1 Clinical summary This diagnostic test evaluates the FAM111A gene for pathogenic variants associated with Kenny‑Caffey syndrome type 2.
TEST-5393 FAM83H Gene Amelogenesis Imperfecta, Type III, Genetic Test This test identifies pathogenic variants in the FAM83H gene associated with Amelogenesis Imperfecta Type III.	Peripheral Whole Blood (EDTA Tube) or FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the FAM83H gene", "Single nucleotide variants", "Small insertions/deletions"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any medications"] Indications ["Diagnosis of Amelogenesis Imperfecta Type III", "Distinguishing hypocalcified enamel defects", "Genetic counseling for inheritance patterns"] Measurement technique Confirm with laboratory Codes LOINC: 96533-1 ICD-10: K00.5 Clinical summary This test identifies pathogenic variants in the FAM83H gene associated with Amelogenesis Imperfecta Type III.
TEST-2787 FAT4 Gene Hennekam Lymphangiectasia‑Lymphedema Syndrome Type 2 Genetic Test This test identifies pathogenic variants in the FAT4 gene associated with Hennekam lymphangiectasia‑lymphedema syndrome type 2.	Whole Blood, Extracted DNA, or One Drop Blood on FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the FAT4 gene", "Single nucleotide variants", "Small insertions or deletions"] Parameters [] Preparation ["No special dietary or medication restrictions", "Disclose recent blood transfusion (within 2 weeks)"] Indications ["Suspected Hennekam lymphangiectasia‑lymphedema syndrome type 2", "Individuals with clinical features suggestive of the syndrome", "Family history of FAT4-related Hennekam syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Q87.8 Clinical summary This test identifies pathogenic variants in the FAT4 gene associated with Hennekam lymphangiectasia‑lymphedema syndrome type 2.
TEST-3445 FGF8 Gene Genetic Test for Hypogonadotropic Hypogonadism Type 6 (with or without Anosmia) This test evaluates the FGF8 gene for mutations associated with congenital hypogonadotropic hypogonadism type 6.	Whole Blood, Extracted DNA, or FTA Card	3-4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["FGF8 gene sequence", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (indels)", "Copy Number Variations (CNVs)"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Diagnosis of congenital hypogonadotropic hypogonadism type 6", "Evaluation of delayed puberty with anosmia", "Genetic counseling for affected families"] Measurement technique Confirm with laboratory Codes LOINC: 100339-6 ICD-10: E23.0 Clinical summary This test evaluates the FGF8 gene for mutations associated with congenital hypogonadotropic hypogonadism type 6.

Category overview

Single Gene: overview

When clinical symptoms or family history point directly toward a specific inherited condition, highly focused genetic testing provides the exact, rapid insights necessary for peace of mind. Integrated into our advanced Molecular Genetics services, Single Gene testing meticulously analyzes one specific gene for known disease-causing mutations. Utilizing cutting-edge diagnostic technology, this highly focused molecular screening helps confirm or rule out precise genetic traits, safely guiding targeted medical interventions and family planning strategies. Recognized for specialized diagnostic excellence among diagnostic labs in the UAE, DNA Labs ensures absolute patient confidentiality, exceptional analytical precision, and incredibly efficient turnaround times. Take an informed step forward in your health journey—schedule your single gene testing in UAE, book a secure home sample collection, or reach out to our expert medical professionals.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.